Intensity Therapeutics Says Stockholder Armistice Capital May Sell 1.24 Million Shares

MT NewswiresDec 14 05:48

Intensity Therapeutics Reports Positive Results of INT230-6 in Breast Cancer

Yahoo FinanceDec 13 21:10

Intensity Therapeutics Shares Are Trading Lower. The Company Presented Final Data From Intensity's INVINCIBLE-2 Study and an Overview/update of the INVINCIBLE-4 Study.

BenzingaDec 13 02:14

Intensity Therapeutics Says Cancer Drug Candidate Shows Benefits in Phase 2 Trial

MT NewswiresDec 13 00:26

Intensity Therapeutics And The Swiss Group For Clinical Cancer Research SAKK Highlight Dec. 11 Presentation Of Phase 2 Breast Cancer Data From Completed INVINCIBLE-2 Study At 2024 San Antonio Breast Cancer Symposium

BenzingaDec 12 21:05

Intensity Therapeutics Analyst Ratings

BenzingaNov 22 01:59 · Ratings